<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/9189</identifier>
				<datestamp>2025-03-26T17:14:51Z</datestamp>
				<setSpec>aabp:RS</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Evaluating the efficacy of Tri-Shield® First Defense® as a treatment for diarrhea in pre-weaned dairy calves</dc:title>
	<dc:creator xml:lang="en">Havekes, C.</dc:creator>
	<dc:creator xml:lang="en">Thomas, M.</dc:creator>
	<dc:creator xml:lang="en">Lichdi, R.</dc:creator>
	<dc:creator xml:lang="en">Gohlert, M.</dc:creator>
	<dc:creator xml:lang="en">Record, C.</dc:creator>
	<dc:creator xml:lang="en">Stangaferro, M.</dc:creator>
	<dc:description xml:lang="en">Diarrhea in pre-weaned dairy calves remains a challenge. An­tibiotic use can often be inappropriate and adversely affect the gut microbiome. There exists an opportunity to explore alter­native treatments for early calfhood scours. Tri-Shield® First Defense® is a veterinary biologic derived from hyperimmu­nized bovine colostrum concentrated to a standard potency of antibodies against K99 + E.coli, coronavirus and rotavirus. One dose at birth serves as a scour preventative, reducing mortal­ity and morbidity caused by K99 + E.coli and coronavirus, while also reducing severity and duration of scours caused by rotavi­rus. The objective of this study was to evaluate the efficacy of Tri-Shield® First Defense® as a treatment for diarrhea occurring between 5 and 14 days of age. We hypothesized calves treated with Tri-Shield, in this off-label application, would recover fe­cal consistency sooner, have improved average daily gain, and lower morbidity and mortality than calves treated only with oral electrolytes.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2025-03-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/9189</dc:identifier>
	<dc:identifier>10.21423/aabppro20249189</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; Vol. 58 No. 58 (2024): 2024 AABP Annual Conference Proceedings; 236</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/9189/8845</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
